USP37 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.350000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.893400E-01
Normal-vs-Stage2
8.910800E-01
Normal-vs-Stage3
2.973400E-01
Normal-vs-Stage4
6.182400E-01
Stage1-vs-Stage2
9.822800E-01
Stage1-vs-Stage3
2.147600E-01
Stage1-vs-Stage4
6.391200E-01
Stage2-vs-Stage3
1.459370E-01
Stage2-vs-Stage4
5.797800E-01
Stage3-vs-Stage4
2.079800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.602800E-01
Normal-vs-AfricanAmerican
1.325980E-01
Normal-vs-Asian
9.011200E-01
Caucasian-vs-AfricanAmerican
1.122960E-01
Caucasian-vs-Asian
7.455400E-01
AfricanAmerican-vs-Asian
1.009050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.415200E-01
Normal-vs-Female
9.215800E-01
Male-vs-Female
2.433800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.782800E-01
Normal-vs-Age(41-60Yrs)
4.660200E-01
Normal-vs-Age(61-80Yrs)
8.117400E-01
Normal-vs-Age(81-100Yrs)
6.529000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.443400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.845200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.517000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.158300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.736000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.851800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.023800E-01
Normal-vs-Daily Drinker
7.757400E-01
Normal-vs-Weekly Drinker
4.532600E-01
Normal-vs-Occasional Drinker
6.508400E-01
Normal-vs-Social Drinker
8.235200E-01
Non Drinker-vs-Daily Drinker
6.464400E-01
Non Drinker-vs-Weekly Drinker
3.176600E-01
Non Drinker-vs-Occasional Drinker
1.996610E-01
Non Drinker-vs-Social Drinker
4.861800E-01
Daily Drinker-vs-Weekly Drinker
6.775800E-01
Daily Drinker-vs-Occasional Drinker
1.661190E-01
Daily Drinker-vs-Social Drinker
3.683400E-01
Weekly Drinker-vs-Occasional Drinker
8.079700E-02
Weekly Drinker-vs-Social Drinker
1.792230E-01
Occasional Drinker-vs-Social Drinker
6.585600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.093500E-02
Normal-vs-Grade 2
1.817820E-02
Normal-vs-Grade 3
1.337630E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.593400E-01
Grade 1-vs-Grade 3
5.042400E-01
Grade 1-vs-Grade 4
3.093500E-02
Grade 2-vs-Grade 3
7.352600E-01
Grade 2-vs-Grade 4
1.817820E-02
Grade 3-vs-Grade 4
1.337630E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.719000E-01
Normal-vs-NonDiabetic
9.255400E-01
Diabetic-vs-NonDiabetic
6.700300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.726400E-01
Normal-vs-NoPancreatitis
9.411400E-01
Pancreatitis-vs-NoPancreatitis
6.476400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.333200E-01
Normal-vs-N1
8.834400E-01
N0-vs-N1
4.316400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.239800E-01
Normal-vs-TP53-NonMutant
9.088400E-01
TP53-Mutant-vs-TP53-NonMutant
1.804370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
